Literature DB >> 11560483

Mycobacterium tuberculosis lipoamide dehydrogenase is encoded by Rv0462 and not by the lpdA or lpdB genes.

A Argyrou1, J S Blanchard.   

Abstract

The gene encoding dihydrolipoamide dehydrogenase from Mycobacterium tuberculosis, Rv0462, was expressed in Escherichia coli and the protein purified to homogeneity. The 49 kDa polypeptide forms a homodimer containing one tightly bound molecule of FAD/monomer. The results of steady-state kinetic analyses using several reduced pyridine nucleotide analogs and a variety of electron acceptors, and the ability of the enzyme to catalyze the transhydrogenation of NADH and thio-NAD(+) in the absence of D,L-lipoamide, demonstrated that the enzyme uses a ping-pong kinetic mechanism. Primary deuterium kinetic isotope effects on V and V/K at pH 7.5 using NADH deuterated at the C(4)-proS position of the nicotinamide ring are small [(D)(V/K)(NADH) = 1.12 +/- 0.15, (D)V(app) = 1.05 +/- 0.07] when D,L-lipoamide is the oxidant but large and equivalent [(D)(V/K)(NADH) = (D)V = 2.95 +/- 0.03] when 5-hydroxy-1,4-naphthoquinone is the oxidant. Solvent deuterium kinetic isotope effects at pH 5.8, using APADH as the reductant, are inverse with (D)(V/K)(APADH) = 0.73 +/- 0.03, (D)(V/K)(Lip(S))2 = 0.77 +/- 0.03, and (D)V(app) = 0.77 +/- 0.01. Solvent deuterium kinetic isotope effects with 4,4-dithiopyridine (DTP), the 4-thiopyridone product of which requires no protonation, are also inverse with (D)(V/K)(APADH) = 0.75 +/- 0.06, (D)(V/K)(DTP) = 0.71 +/- 0.02, and (D)V(app) = 0.56 +/- 0.15. All proton inventories were linear, indicating that a single proton is being transferred in the solvent isotopically sensitive step. Taken together, these results suggest that (1) the reductive half-reaction (hydride transfer from NADH to FAD) is rate limiting when a quinone is the oxidant, and (2) deprotonation of enzymic thiols, most likely Cys(46) and Cys(41), limits the reductive and oxidative half-reactions, respectively, when D,L-lipoamide is the oxidant.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11560483     DOI: 10.1021/bi010575o

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

Review 1.  Lipoic acid metabolism in microbial pathogens.

Authors:  Maroya D Spalding; Sean T Prigge
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

2.  Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier.

Authors:  Kyu Y Rhee; Luiz Pedro Sorio de Carvalho; Ruslana Bryk; Sabine Ehrt; Joeli Marrero; Sae Woong Park; Dirk Schnappinger; Aditya Venugopal; Carl Nathan
Journal:  Trends Microbiol       Date:  2011-05-10       Impact factor: 17.079

3.  TGL-mediated lipolysis in Manduca sexta fat body: possible roles for lipoamide-dehydrogenase (LipDH) and high-density lipophorin (HDLp).

Authors:  Zengying Wu; Jose L Soulages; Bharat D Joshi; Stuart M Daniel; Zachary J Hager; Estela L Arrese
Journal:  Insect Biochem Mol Biol       Date:  2013-12-12       Impact factor: 4.714

4.  Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes.

Authors:  Aditya Venugopal; Ruslana Bryk; Shuangping Shi; Kyu Rhee; Poonam Rath; Dirk Schnappinger; Sabine Ehrt; Carl Nathan
Journal:  Cell Host Microbe       Date:  2011-01-20       Impact factor: 21.023

5.  Lipoamide channel-binding sulfonamides selectively inhibit mycobacterial lipoamide dehydrogenase.

Authors:  Ruslana Bryk; Nancy Arango; Christina Maksymiuk; Anand Balakrishnan; Ying-Ta Wu; Chi-Huey Wong; Thierry Masquelin; Philip Hipskind; Christopher D Lima; Carl Nathan
Journal:  Biochemistry       Date:  2013-11-26       Impact factor: 3.162

6.  S-nitroso proteome of Mycobacterium tuberculosis: Enzymes of intermediary metabolism and antioxidant defense.

Authors:  Kyu Y Rhee; Hediye Erdjument-Bromage; Paul Tempst; Carl F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-30       Impact factor: 11.205

7.  Activity-based metabolomic profiling of enzymatic function: identification of Rv1248c as a mycobacterial 2-hydroxy-3-oxoadipate synthase.

Authors:  Luiz Pedro S de Carvalho; Hong Zhao; Caitlyn E Dickinson; Nancy M Arango; Christopher D Lima; Steven M Fischer; Ouathek Ouerfelli; Carl Nathan; Kyu Y Rhee
Journal:  Chem Biol       Date:  2010-04-23

8.  Triazaspirodimethoxybenzoyls as selective inhibitors of mycobacterial lipoamide dehydrogenase .

Authors:  Ruslana Bryk; Nancy Arango; Aditya Venugopal; J David Warren; Yun-Hee Park; Mulchand S Patel; Christopher D Lima; Carl Nathan
Journal:  Biochemistry       Date:  2010-03-02       Impact factor: 3.162

9.  Selective killing of nonreplicating mycobacteria.

Authors:  Ruslana Bryk; Benjamin Gold; Aditya Venugopal; Jasbir Singh; Raghu Samy; Krzysztof Pupek; Hua Cao; Carmen Popescu; Mark Gurney; Srinivas Hotha; Joseph Cherian; Kyu Rhee; Lan Ly; Paul J Converse; Sabine Ehrt; Omar Vandal; Xiuju Jiang; Jean Schneider; Gang Lin; Carl Nathan
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

10.  An anaerobic-type alpha-ketoglutarate ferredoxin oxidoreductase completes the oxidative tricarboxylic acid cycle of Mycobacterium tuberculosis.

Authors:  Anthony D Baughn; Scott J Garforth; Catherine Vilchèze; William R Jacobs
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.